Viewing Study NCT01016093


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2025-12-25 @ 11:21 PM
Study NCT ID: NCT01016093
Status: UNKNOWN
Last Update Posted: 2011-07-26
First Post: 2009-11-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major Patients
Sponsor: Tehran University of Medical Sciences
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2009-11
Start Date Type: None
Primary Completion Date: 2011-11
Primary Completion Date Type: ESTIMATED
Completion Date: 2011-12
Completion Date Type: ESTIMATED
First Submit Date: 2009-11-17
First Submit QC Date: None
Study First Post Date: 2009-11-18
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-07-25
Last Update Post Date: 2011-07-26
Last Update Post Date Type: ESTIMATED